9582
B. Chevalier-du Roizel et al. / Tetrahedron 58 (2002) 9579–9583
volume as TIBAL) at rt under argon. The reaction mixture
was heated at 508C until TLC (EtOAc/cyclohexane¼1/2)
indicated no starting material but a major product. The
mixture was cooled to 08C, aqueous 1N HCl was carefully
added dropwise, and the mixture was stirred vigorously at rt
for 15 min. The mixture was filtered (Celitew) into a
separating funnel and washed thoroughly with EtOAc. The
organic layer was washed with brine, dried (MgSO4),
filtered and the solvent was removed in vacuo. The residue
Hz, CHHPh), 4.71 (d, 1H, J1–2¼1.3 Hz, H-1), 4.67 (d, 1H,
Jgem¼11.7 Hz, CHHPh), 4.06 (dd, 1H, J5 –6a¼4.5 Hz,
Jgem¼10.0 Hz, H-6a), 3.85 (dd, 1H, J2–3¼3.8 Hz, J3–4
¼
9.8 Hz, H-3), 3.77 (dd, 1H, J2–3¼3.8 Hz, J1–2¼1.3 Hz,
H-2), 3.68 (t, 1H, H-4), 3.62 (t, 1H, H-6b), 3.57 (dd, 1H,
Jgem¼14.7 Hz, J7–8a¼4.7 Hz, H-8a), 3.54 (td, 1H, J4–5
,
J5 – 6b,2£J5 – 6a, H-5), 3.51 (dd, 1H, Jgem¼14.7 Hz,
J7– 8b¼5.3 Hz, H-8b), 3.32 (s, 3H, OMe); 13C NMR
(CDCl3, TMS) d 139.8, 137.3 (2£Cquat-Ar), 133.8, 129.0,
128.6, 128.4, 128.2, 127.9 (10£CH-Ar), 99.1 (C-1), 97.0
(C-7), 79.4 (C-4), 78.3 (C-2), 73.7 (CH2Ph), 68.4 (C-6), 68.2
(C-3), 62.6 (C-5), 59.9 (C-8), 55.0 (OMe); Anal. calcd for
C22H26O8S (450.50): C, 58.65; H, 5.82, found: C, 58.86; H,
6.12%.
was
purified
by
flash
chromatography
(EtOAc/cyclohexane¼1/1) to afford the de-O-benzylated
product as a colourless foam.
4.2.1. Methyl 3-O-benzyl-4,6-O-(2-phenylsulfonyl)-ethyl-
idene-a-D-glucopyranoside (2). Compound 1 (309 mg,
0.57 mmol) was submitted to TIBAL (3.4 mL, 3.4 mmol,
1 M, 6 equiv.) in anhydrous toluene (3.5 mL), to afford,
after stirring 2 h at 508C, the mono-benzyl ether 2 (250 mg,
97%) as a colourless foam: [a]2D3¼þ102 (c 1.0, CHCl3); MS
4.2.3. Methyl 2-O-benzyl-4,6-O-(2-phenylsulfonyl)-ethyl-
idene-a-D-altropyranoside (7). Starting material
6
(105 mg, 0.20 mmol) was submitted to TIBAL (1.2 mL,
1.20 mmol, 1 M, 6 equiv.) in anhydrous toluene (1.2 mL), to
afford, after stirring 1 h at 508C, mono-benzyl ether 7
(84 mg, 97%) as a colourless foam: [a]2D3¼þ45 (c 1.0,
1
(CI) m/z 468 [MNH4]þ; H NMR (CDCl3) d 5.04 (t, 1H,
J7–8¼4.9 Hz, H-7), 4.86 (d, 1H, Jgem¼11.6 Hz, CHHPh),
4.77 (d, 1H, J1–2¼3.0 Hz, H-1), 4.71 (d, 1H, Jgem¼11.6 Hz,
CHHPh), 4.08 (dd, 1H, J5–6a¼4.8 Hz, Jgem¼10.2 Hz,
1
CHCl3); MS (CI) m/z 468 [MNH4]þ; H NMR (CDCl3) d
7.94–7.35 (m, 10H, 10£H-Ar), 5.16 (t, 1H, J7–8¼4.9 Hz,
H-7), 4.69 (br s, 1H, H-1), 4.63 (br s, 2H, CH2Ph), 4.11 (dd,
1H, Jgem¼10.3 Hz, J5–6a¼5.1 Hz, H-6a), 3.98 (br s, 1H,
H-3), 3.94 (td, 1H, J4–5,J5–6b,2£J5–6a, H-5), 3.76 (dd,
1H, J3–4¼2.9 Hz, J4–5¼9.9 Hz, H-4), 3.67 (br d, 1H,
J2–3¼3.2 Hz, H-2), 3.63 (t, 1H, J5–6b¼Jgem¼10.0 Hz,
H-6b), 3.57 (dd, 1H, Jgem¼14.6 Hz, J7–8a¼4.7 Hz, H-8a),
3.53 (dd, 1H, Jgem¼14.6 Hz, J7–8b¼5.1 Hz, H-8b), 3.37 (s,
3H, OMe); 13C NMR (CDCl3, TMS) d 139.6, 137.0
(2£Cquat-Ar), 133.7, 129.1–127.7 (10£CH-Ar), 99.8
(C-1), 97.2 (C-7), 76.4 (C-4), 76.3 (C-2), 72.5 (CH2Ph),
68.6 (C-6), 66.7 (C-3), 59.9 (C-8), 57.6 (C-5), 55.5 (OMe);
Anal. calcd for C22H26O8S (450.50): C, 58.65; H, 5.82,
found: C, 58.65; H, 6.14%.
H-6a), 3.68 (m, 2H, H-2þH-4), 3.53 (t, 1H, J5–6b
,
J6a–6b,10.0 Hz, H-6b), 3.51 (d, 2H, J7–8¼4.9 Hz, H-8),
3.43 (m, 1H, H-3), 3.42 (s, 3H, OMe); 13C NMR (CDCl3,
TMS) d 139.7, 138.3 (2£Cquat-Ar), 133.9, 129.1, 128.3,
128.1, 127.9, 127.7 (10£CH-Ar), 99.7 (C-1), 96.5 (C-7),
81.6 (C-3), 78.3 (C-4), 74.5 (CH2Ph), 72.1 (C-2), 68.5 (C-6),
61.9 (C-5), 59.9 (C-8), 55.4 (OMe); Anal. calcd for
C22H26O8S (450.50): C, 58.65; H, 5.82, found: C, 58.51;
H, 5.97%.
4.2.2. Methyl 3-O-benzyl-4,6-O-(2-phenylsulfonyl)-ethyl-
idene-a-D-mannopyranoside (4), methyl 2-O-benzyl-4,6-
O-(2-phenylsulfonyl)-ethylidene-a-D-mannopyranoside
(5). The precursor 3 (150 mg, 0.28 mmol) was submitted
to TIBAL (1.7 mL, 1.70 mmol, 1 M, 6 equiv.) in
anhydrous toluene (1.7 mL), to afford, after stirring 2 h at
508C, first, side-product 5 (12 mg, 10%), followed by major
product 4 (100 mg, 80%) both in the form of colourless
foams:
4.2.4. Methyl 3-O-benzyl-4,6-O-(2-phenylsulfonyl)-ethyl-
idene-a-D-allopyranoside (9), methyl 2-O-benzyl-4,6-O-
(2-phenylsulfonyl)-ethylidene-a-D-allopyranoside (10)
and 2,3-di-O-benzyl-4,6-O-(2-phenylsulfonyl)-ethyl-
idene-D-allitol (11). The precursor 8 (105 mg, 0.2 mmol)
was submitted to TIBAL (1.2 mL, 1.20 mmol, 1 M,
6 equiv.) in anhydrous toluene (1.2 mL), to afford, after
stirring 1 h at 508C, first, a mixture of compounds 9 and 11
(38 mg, 44%, 1:3), followed by 10 (48 mg, 55%), all in the
form of colourless foams. NMR data for compounds 9 and
11 were extrapolated from the NMR spectra of a sample of
their mixture. As a consequence, neither elemental analysis
nor optical rotation are given.
Compound 4. [a]2D3¼þ74 (c 1.0, CHCl3); MS (CI) m/z 468
[MNH4]þ; 1H NMR (CDCl3) d 7.97–7.38 (m, 10H, 10£CH-
Ar), 5.06 (t, 1H, J7–8¼4.9 Hz, H-7), 4.78 (d, 1H, Jgem¼11.9
Hz, CHHPh), 4.70 (d, 1H, J1–2¼1.3 Hz, H-1), 4.62 (d, 1H,
Jgem¼11.9 Hz, CHHPh), 4.05 (m, 1H, H-6a), 3.98 (dd, 1H,
J1–2¼1.3 Hz, J2–3¼3.4 Hz, H-2), 3.88 (br t, 1H, H-4), 3.74
(dd, 1H, J2–3¼3.4 Hz, J3–4¼9.5 Hz, H-3), 3.65–3.57 (m,
2H, H-5þH-6b), 3.54 (dd, 1H, Jgem¼14.5 Hz, J7–8a
¼
4.4 Hz, H-8a), 3.50 (dd, 1H, Jgem¼14.5 Hz, J7–8b¼5.2 Hz,
H-8b), 3.34 (s, 3H, OMe); 13C NMR (CDCl3, TMS) d
139.6, 137.8 (2£Cquat-Ar), 133.8, 129.1, 128.4, 128.1,
127.8, 127.7 (10£CH-Ar), 100.9 (C-1), 96.8 (C-7), 78.6
(C-4), 75.1 (C-3), 72.7 (CH2Ph), 69.5 (C-2), 68.4 (C-6),
62.5 (C-5), 59.9 (C-8), 54.9 (OMe); Anal. calcd for
C22H26O8S (450.50): C, 58.65; H, 5.82, found: C, 58.51;
H, 5.87%.
Compound 9. MS (CI) m/z 468 [MNH4]þ; 1H NMR (CDCl3)
d 7.94–7.30 (m, 10H, 10£H-Ar), 5.08 (t, 1H, J7–8¼4.9 Hz,
H-7), 4.64 (d, 1H, J1– 2¼3.7 Hz, H-1), 4.44 (d, 1H,
Jgem¼12.1 Hz, CHHPh), 4.26 (d, 1H, Jgem¼12.1 Hz,
CHHPh), 4.16 (m, 1H, H-6a), 4.02 (m, 1H, H-5), 3.86 (br
t, 1H, J2–3,J3–4,3.1 Hz, H-3), 3.64 (br m, 1H, H-2), 3.50
(m, 3H, H-8þH-6b), 3.40 (s, 3H, OMe), 3.39 (dd, 1H,
J4–5¼9.8 Hz, J3–4¼3.1 Hz, H-4); 13C NMR (CDCl3, TMS)
d 139.8, 138.6, (2£Cquat-Ar), 133.8, 129.0–127.1 (10£CH-
Ar), 99.7 (C-1), 96.9 (C-7), 79.1 (C-4), 75.9 (C-3), 74.5
(CH2Ph), 68.9 (C-6), 67.7 (C-2), 59.9 (C-8), 56.9 (C-5), 56.2
(OMe).
Compound 5. [a]2D3¼þ10 (c 0.5, CHCl3); MS (CI) m/z 468
[MNH4]þ; 1H NMR (CDCl3) d 7.98–7.30 (m, 10H, 10£CH-
Ar), 5.11 (t, 1H, J7–8¼4.5 Hz, H-7), 4.74 (d, 1H, Jgem¼11.7